scispace - formally typeset
S

Sandro Sironi

Researcher at University of Milan

Publications -  118
Citations -  3390

Sandro Sironi is an academic researcher from University of Milan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 26, co-authored 65 publications receiving 3140 citations. Previous affiliations of Sandro Sironi include Vita-Salute San Raffaele University.

Papers
More filters
Journal ArticleDOI

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.

TL;DR: RF ablation appears to be a simple, safe, and potentially effective treatment for selected patients with liver metastases and may become a less invasive alternative to surgical therapy.
Journal ArticleDOI

Hepatic metastases : percutaneous radio-frequency ablation with cooled-tip electrodes

TL;DR: Use of cooled-tip electrodes was a safe and feasible adjunct for tumorRF ablation therapy that produced larger volumes of coagulation necrosis with fewer electrode insertions than is produced with other RF ablation techniques.
Journal Article

Peripheral and abdominal adiposity in childhood obesity.

TL;DR: It was concluded that childhood obesity has a subcutaneous adipose pattern with no differences between the sexes and IAT already begins to have clinical significance since it has a relationship to some cardiovascular risk factors.
Journal ArticleDOI

Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging.

TL;DR: The use of contrast material may improve the ability to assess, with MR imaging, the depth of myometrial invasion by endometrial cancer.
Journal ArticleDOI

Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy.

TL;DR: CT-guided pancreatic FNAB is the most reliable examination for enabling differential diagnosis of pancreatic cancer and chronic pancreatitis when the pancreas is well visualized at US, and the negative predictive value for pancreaticcancer is more accurate than that of CA 19-9 assessment and CT.